Cargando…

Targeting substrate-site in Jak2 kinase prevents emergence of genetic resistance

Emergence of genetic resistance against kinase inhibitors poses a great challenge for durable therapeutic response. Here, we report a novel mechanism of JAK2 kinase inhibition by fedratinib (TG101348) that prevents emergence of genetic resistance. Using in vitro drug screening, we identified 211 ami...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kesarwani, Meenu, Huber, Erika, Kincaid, Zachary, Evelyn, Chris R., Biesiada, Jacek, Rance, Mark, Thapa, Mahendra B., Shah, Neil P., Meller, Jarek, Zheng, Yi, Azam, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588578/ https://www.ncbi.nlm.nih.gov/pubmed/26419724 http://dx.doi.org/10.1038/srep14538

Ejemplares similares

MEK/ERK addiction in CNL/aCML
por: Kesarwani, Meenu, et al.
Publicado: (2017)

Enhanced MAPK signaling is essential for CSF3R induced leukemia
por: Rohrabaugh, Sara, et al.
Publicado: (2016)

Momelotinib is a highly potent inhibitor of FLT3-mutant AML
por: Azhar, Mohammad, et al.
Publicado: (2022)

Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AML
por: Azhar, Mohammad, et al.
Publicado: (2022)

Substrate specificity of Tulane virus protease
por: Wei, Chao, et al.
Publicado: (2013)

c-Fos and Dusp1 confer non-oncogene addiction in BCR-ABL induced leukemia
por: Kesarwani, Meenu, et al.
Publicado: (2017)

Tubulosine selectively inhibits JAK3 signalling by binding to the ATP‐binding site of the kinase of JAK3
por: Kim, Byung‐Hak, et al.
Publicado: (2020)

Overcoming AC220 resistance of FLT3-ITD by SAR302503
por: Kesarwani, M, et al.
Publicado: (2013)

The Janus kinases (Jaks)
por: Yamaoka, Kunihiro, et al.
Publicado: (2004)

Identifying Protein Phosphorylation Sites with Kinase Substrate Specificity on Human Viruses
por: Bretaña, Neil Arvin, et al.
Publicado: (2012)

F201. KINASE NETWORK DYSREGULATION IN SCHIZOPHRENIA: IMPLICATIONS FOR NEW TREATMENT STRATEGIES
por: Bentea, Eduard, et al.
Publicado: (2018)

Evolution of protein kinase substrate recognition at the active site
por: Bradley, David, et al.
Publicado: (2019)

Prediction of Kinase-Substrate Associations Using The Functional Landscape of Kinases and Phosphorylation Sites
por: Ayati, Marzieh, et al.
Publicado: (2023)

Folliculin Contributes to VHL Tumor Suppressing Activity in Renal Cancer through Regulation of Autophagy
por: Bastola, Prabhat, et al.
Publicado: (2013)

JAK Kinases in Health and Disease: An Update
por: Laurence, Arian, et al.
Publicado: (2012)

UQlust: combining profile hashing with linear-time ranking for efficient clustering and analysis of big macromolecular data
por: Adamczak, Rafal, et al.
Publicado: (2016)

Comprehensive Identification and Modified-Site Mapping of S-Nitrosylated Targets in Prostate Epithelial Cells
por: Lam, Ying Wai, et al.
Publicado: (2010)

Survey of public domain software for docking simulations and virtual screening
por: Biesiada, Jacek, et al.
Publicado: (2011)

Molecular Docking Simulations Provide Insights in the Substrate Binding Sites and Possible Substrates of the ABCC6 Transporter
por: Hosen, Mohammad Jakir, et al.
Publicado: (2014)

Mucosal Epithelial Jak Kinases in Health and Diseases
por: Kumar, Narendra, et al.
Publicado: (2021)

pkaPS: prediction of protein kinase A phosphorylation sites with the simplified kinase-substrate binding model
por: Neuberger, Georg, et al.
Publicado: (2007)

A Novel Phosphorylation Site-Kinase Network-Based Method for the Accurate Prediction of Kinase-Substrate Relationships
por: Wang, Minghui, et al.
Publicado: (2017)

The Janus Kinase (JAK) FERM and SH2 Domains: Bringing Specificity to JAK–Receptor Interactions
por: Ferrao, Ryan, et al.
Publicado: (2017)

Small Molecule Substrate Phosphorylation Site Inhibitors of Protein Kinases: Approaches and Challenges
por: Breen, Meghan E., et al.
Publicado: (2014)

JAK kinase inhibitors for the treatment of acute lymphoblastic leukemia
por: Degryse, Sandrine, et al.
Publicado: (2015)

Mechanistic Insights into Regulation of JAK2 Tyrosine Kinase
por: Hubbard, Stevan R.
Publicado: (2018)

Kinase-interacting substrate screening is a novel method to identify kinase substrates
por: Amano, Mutsuki, et al.
Publicado: (2015)

S183. ABNORMALITIES IN SERINE/THREONINE SIGNALING NETWORKS IN SEVERE NEUROPSYCHIATRIC ILLNESS: DEVELOPMENT OF A PIPELINE TO EXPLORE ABNORMALITIES OF KINASE ACTIVITY AND IDENTIFY NOVEL TREATMENT STRATEGIES FOR SCHIZOPHRENIA
por: McCullumsmith, Robert, et al.
Publicado: (2020)

Isoprenoid Phosphonophosphates as Glycosyltransferase Acceptor Substrates
por: Martinez Farias, Mario A., et al.
Publicado: (2014)

Differential Requirements for Clathrin-dependent Endocytosis at Sites of Cell–Substrate Adhesion
por: Batchelder, Erika M., et al.
Publicado: (2010)

Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
por: Blume-Peytavi, Ulrike, et al.
Publicado: (2015)

Immunohistochemistry of Janus Kinase 1 (JAK1) Expression in Vitiligo
por: Abdou, Asmaa Gaber, et al.
Publicado: (2018)

Activation of Jak2 in patients with blast crisis chronic myelogenous leukemia: inhibition of Jak2 inactivates Lyn kinase
por: Chakraborty, S, et al.
Publicado: (2013)

IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer models
por: Gasilina, Anjelika, et al.
Publicado: (2020)

SILAC kinase screen identifies potential MASTL substrates
por: Marzec, Kamila A., et al.
Publicado: (2022)

32.2 ABNORMALITIES OF SYNAPTIC PROTEOMES IN SCHIZOPHRENIA
por: Funk, Adam, et al.
Publicado: (2018)

Editorial: Driving extracellular vesicles toward applications in precision medicine
por: Chutipongtanate, Somchai, et al.
Publicado: (2022)

Effects of a small, volatile bacterial molecule on Pseudomonas aeruginosa bacteria using whole cell high-resolution magic angle spinning nuclear magnetic resonance spectroscopy and genomics
por: Righi, Valeria, et al.
Publicado: (2018)

Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis
por: Morelli, Martina, et al.
Publicado: (2018)

The SH2 domain and kinase activity of JAK2 target JAK2 to centrosome and regulate cell growth and centrosome amplification
por: Shahi, Aashirwad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2foikne6os46oecb98c72cio38